SPECIAL FEATURE - Injection Devices: Manufacturers Focus on 21st ...
Formulations and storage conditions for GLP-1 RA products ...
Bydureon Single Dose Trays to Be Discontinued - Endocrinology Advisor
Select your BYDUREON® (exenatide extended-release) injectable ...
Type 2 Diabetes Drug Bydureon Gets a Makeover - GoodRx
PhactMI BYDUREON® BCise™ (exenatide extended-release)
Exenatid QW v předplněném peru – Aktuality – Články – Remedia ...
Pre-filled pen injector for adults with type 2 diabetes
WO2013086292A1 - Glucagon formulations - Google Patents
Update on GLP-1 Agonists in Type 2 Diabetes is supported by an ...
Exenatide: pharmacokinetics, clinical use, and future directions
Select your BYDUREON® (exenatide extended-release) injectable ...
Once-weekly exenatide pen gets EC nod | Future Medicine India
Novel Transdermal -‐ Regulatory Landscape and Glucose Sensing and ...
Drug Delivery Experts - EuroTIDES 08NOV2017
PhactMI BYDUREON® BCise™ (exenatide extended-release)
AZN - Page 3 of 7
Innovative Drug Platform & Formulation Technologies
Bydureon 2 mg powder and solvent for prolonged-release suspension ...
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
NEW ZEALAND DATA SHEET 1. PRODUCT NAME 2. QUALITATIVE AND ...
